Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis
Acta Obstetricia et Gynecologica Scandinavica · 2023-09 · 102 (9) · 1159-1175
DOI: 10.1111/aogs.14617 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 22.06.2023. Verfasst von Sarah Annie Solangon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Women's Health, University College London, London, UK. Hauptthemen laut MEDLINE: Pregnancy, Tubal, Pregnancy, Ectopic, Abortifacient Agents, Nonsteroidal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction Ectopic pregnancy is an important health condition which affects up to 1 in 100 women. Women who present with mild symptoms and low serum human chorionic gonadotrophin (hCG) are often treated with methotrexate (MTX), but expectant management with close monitoring is a feasible alternative. Studies comparing the two treatments have not shown a statistically significant difference in uneventful resolution of ectopic pregnancy, but these studies were too small to define whether certain subgroups could benefit more from either treatment. Material and methods We performed a systematic review and individual participant data meta‐analysis (IPD‐MA) of randomized controlled trials comparing systemic MTX and expectant management in women with tubal ectopic pregnancy and low hCG (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Women's Health, University College London, London, UK.
- Center for Reproductive Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Amsterdam Reproduction and Development Research Institute, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Obstetrics and Gynecology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- The Ritchie Centre, Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia.
- Aberdeen Centre for Women's Health Research, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
ORCID-Profile: Sarah Annie Solangon, Madelon Van Wely, Norah Van Mello, Ben W Mol, Jackie A Ross, Davor Jurkovic
Zitieren
APA
Solangon, S. A., Van Wely, M., Van Mello, N., Mol, B. W., Ross, J. A., & Jurkovic, D. (2023). Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica, 102(9), 1159-1175. https://doi.org/10.1111/aogs.14617
Vancouver
Solangon SA, Van Wely M, Van Mello N, Mol BW, Ross JA, Jurkovic D. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis. Acta Obstetricia et Gynecologica Scandinavica. 2023;102(9):1159-1175. doi:10.1111/aogs.14617
BibTeX
@article{Solangon2023,
author = {Solangon, Sarah Annie and Van Wely, Madelon and Van Mello, Norah and Mol, Ben W and Ross, Jackie A and Jurkovic, Davor},
title = {Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta‐analysis},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2023},
volume = {102},
number = {9},
pages = {1159--1175},
doi = {10.1111/aogs.14617}
}
EUVIMED